Mylan Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Mylan careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

job id - 18000547At Mylan, each person has the ability to make a difference. From the providers who sell and market our products, to the producers who develop and manufacture them and finally to our business partners who support the providers and ...
Posted: April 21, 2018, 12:07 am
job id - 18000333 At Mylan, each person has the ability to make a difference. From the providers who sell and market our products, to the producers who develop and manufacture them and finally to our business partners who support the providers an...
Posted: April 21, 2018, 12:07 am
job id - 18000179At Mylan, each person has the ability to make a difference. From the providers who sell and market our products, to the producers who develop and manufacture them and finally to our business partners who support the providers and ...
Posted: April 21, 2018, 12:07 am
job id - 18000546-76eb9c4890b97a22520e0ae32 At Mylan, each person has the ability to make a difference. From the providers who sell and market our products, to the producers who develop and manufacture them and finally to our business partners wh...
Posted: April 21, 2018, 12:07 am
job id-18000590 Support cross-functional initiatives impacting U.S. Commercial Compliance. Assist in performing monitoring/auditing and periodic assessments of company operations and business environments to identify potential compliance risk ...
Posted: April 20, 2018, 1:09 am

Viewing page 1 of 15|Next Page

  Newsfeed | Subscribe  

EpiPens are manufactured for Mylan by Pfizer Inc (PFE.N) at a plant in St. Louis, which has experienced production problems that have led to shortages in some international markets, including Canada and Britain.
Posted: April 20, 2018, 10:13 am
The Morgantown plant is not involved in EpiPen production. EpiPens are manufactured for Mylan by Pfizer Inc at a plant in St. Louis, which has experienced production problems that have led to shortages in some international markets, including Cana...
Posted: April 20, 2018, 10:09 am
Yet, Fadia’s comments may have understated the potential of Mylan’s pipeline. In the queue are a biosimilar versions of Neulasta and Humira. The former is an immune system booster for cancer patients, made by Amgen, Inc. (NASDAQ:AMGN). Humira ......
Posted: April 19, 2018, 12:48 pm
Mylan shares fell as much as 3.7 percent on Friday but pared ... market have been grappling with pricing pressure stoked by online players such as Amazon.com Inc and private label competitors. However, buyers and sellers have struggled to agree on...
Posted: April 13, 2018, 2:49 pm
WallStEquities.com has initiated research reports on the following Drugs - Generic stocks: Mylan N.V. (NASDAQ: MYL), Momenta Pharmaceuticals Inc. (NASDAQ: MNTA), Rigel Pharmaceuticals Inc. (NASDAQ: RIGL), and SCYNEXIS Inc. (NASDAQ: SCYX). All you ...
Posted: April 13, 2018, 4:25 am

Viewing page 1 of 2|Next Page